Patients Benefit From Statin-Ibrutinib Combo

Research shows improved survival outcomes with statin use in patients with chronic lymphocytic leukemia receiving ibrutinib treatment.
Medscape Medical News

source https://www.medscape.com/viewarticle/patients-benefit-statin-ibrutinib-combo-2025a1000a3c?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost